Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.
about
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicineTreatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials.Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodesLocoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 RandomMLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.Learning from big data: are we undertreating older women with high-risk breast cancer?Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.Metastatic breast cancer: Endocrine therapy landscape reshaped.Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.Optimal management of luminal breast cancer: how much endocrine therapy is long enough?Prophylactic mastectomy for the prevention of breast cancer: Review of the literatureGenomic Testing in the Management of Early-Stage Breast CancerAssociation between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast CancerInborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality
P2860
Q33731350-6AA77A32-9148-4826-BDF9-72197EAD6BB8Q36413980-7C388D8F-0BA9-4A41-A409-7391D5CA3EE9Q37241359-1CC141ED-0E9C-4B68-8767-F661EF27AC5DQ38681547-8D07E204-154B-424A-B5B8-B7399DD424E4Q38704901-56CAA147-AFDA-4ECB-8DA5-7F62DACE792EQ38722951-31789ED6-0475-49FA-9BAA-0C67ECAE982CQ38796922-E2FF7359-0FFF-45AF-B9E7-D11CFD9E6E4DQ39500625-948BD37A-A1B1-41D5-A31E-C61CD8876017Q41072269-5159C13D-C6E0-4FE3-A875-ED2C1089B31CQ42334187-7893CDB0-EF55-4A56-8996-C0585FAA8EBDQ44296908-35A154AE-63EB-459C-B376-999B6B8C554FQ45072397-C86363ED-0AC1-46F3-BED3-48EF2339A4E4Q46165703-D140BB1D-068D-45E2-9749-47823553A8BAQ49517068-4D08EFF4-6CCE-49C5-8CCB-ADD7CE51D0B1Q51772667-E464D625-0832-4238-8125-047CF9E3899AQ55280867-FEF84D5B-F93E-4F8C-8D76-F0C2A272F4F7Q55424072-38E52EDC-E6E4-4B33-B02E-E4330397ABD4Q57110065-BA8A109E-0037-4315-936F-58472D623895Q57117421-0BBC2CF7-B95F-4BBE-81BD-E14015F67FC4Q58776754-F6073540-3EF0-4538-9930-2271ABD444A2Q58801103-22C0ED42-59EE-49C7-8E8B-699FE705DF39
P2860
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@en
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@nl
type
label
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@en
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@nl
prefLabel
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@en
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@nl
P2093
P2860
P356
P1476
Annual Hazard Rates of Recurre ...... cer Study Group Trials I to V.
@en
P2093
Alan S Coates
Aron Goldhirsch
Beat Thürlimann
John F Forbes
Karen N Price
Lorenzo Gianni
Monica Castiglione
Per Karlsson
Richard D Gelber
Zhuoxin Sun
P2860
P304
P356
10.1200/JCO.2015.62.3504
P407
P577
2016-01-19T00:00:00Z